Skip to main content
SpringerLink
Log in

Case of a Girl on Psychotropic Medications Seeking Birth Control

  • Chapter
Adolescent Gynecology

  • 911 Accesses

Abstract

For patients with mental health disorders treated with psychotropic medications, contraceptive management can be challenging for the primary care provider. Effectiveness of the combined oral contraceptive may decrease with concomitant use of certain psychotropic medications, although notably SSRIs do not have this interaction. Certain psychotropic medications may convey sexual side effects or hormonal effects such as elevated prolactin levels, elevated androgen levels, and decreased sex hormone-binding globulin, which may lead to clinical symptoms. The lack of effective contraception in patients on psychotropic medications may lead to teratogenic effects in the event of an unplanned pregnancy. Long-acting reversible contraceptives may be a preferred contraceptive method in these patients for improved rate of pregnancy prevention and the avoidance of pharmacologic interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murray CJ, et al. Disability-adjusted life years (DALYS) for 291 diseases and injuries in 21 regions, 1991-2010: a systematic analysis for the Global Burden of Disease study 2010. Lancet. 2012;380(9859):2197–223.

    Article  Google Scholar 

  2. Merikangas KR, et al. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 2009;11(1):7–20.

    PubMed  PubMed Central  Google Scholar 

  3. Burcu M, et al. Atypical antipsychotic use among medicaid-insured children and adolescents: duration, safety, and monitoring implications. J Child Adolesc Psychopharmacol. 2014;24(3):112–9.

    Article  CAS  Google Scholar 

  4. Hall KS, et al. The risk of unintended pregnancy among young women with mental health symptoms. Soc Sci Med. 2014;90:62–71.

    Article  Google Scholar 

  5. Hall KS, et al. Role of young women’s depression and stress symptoms in their weekly use and nonuse of contraceptive methods. J Adolesc Health. 2013;53(2):241–8.

    Article  Google Scholar 

  6. Young EA, et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology. 2007;32:843–53.

    Article  CAS  Google Scholar 

  7. Keyes KM, et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol. 2013;178(9):1378–88.

    Article  Google Scholar 

  8. Pagano HP, et al. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Contraception. 2016;94:641–9. doi:https://doi.org/10.1016/jcontraception.2016.06.012.

  9. Curtis KM, et al. U.S. Medical Eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(RR-3):1–104. doi:https://doi.org/10.15585/mmwr.rr6503a1.

    Article  PubMed  Google Scholar 

  10. Herzog A, et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology. 2009;72(10):911–4.

    Article  CAS  Google Scholar 

  11. LaTorre D, Falorni A. Pharmalogical causes of hyperprolactinemia. Ther Clin Risk Manag. 2007;3(5):929–51.

    CAS  Google Scholar 

  12. Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2006;45:771–91.

    Article  Google Scholar 

  13. Rasgon NL, Altshuler LL, Fairbanks I, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord. 2005;7:246–59.

    Article  Google Scholar 

  14. Bishop JR, et al. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI) associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol. 2009;24(3). https://doi.org/https://doi.org/10.1002/hup 1006.

    Article  CAS  Google Scholar 

  15. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.

    Article  Google Scholar 

  16. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356(9237):1219.

    Article  CAS  Google Scholar 

  17. Bergemann N, et al. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial. Schizophr Bull. 2008;34(6):1172–81.

    Article  Google Scholar 

  18. Hall KS, et al. Contraception and mental health: a commentary on the evidence and principles for practice. Am J Obstet Gynecol. 2015;212(6):740–6.

    Article  Google Scholar 

  19. Gotlib D, et al. Guideline adherence for mentally ill reproductive aged women with valproic acid: a retrospective chart review. J Clin Psychiatry. 2016;77(4):527–34.

    Article  Google Scholar 

  20. ACOG Practice Bulletin: clinical management guidelines for Obstetrician-Gynecologists. 2008;111(4):1001–20.

    Google Scholar 

  21. Finer LB, et al. Changes in use of contraceptive methods in the US, 2007-2009. Fertil Steril. 2012;98(4):893–7.

    Article  Google Scholar 

Suggested Reading

  • AACAP Practice Parameter for the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006

    Google Scholar 

  • ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists. 2008;111(4):1001–20.

    Google Scholar 

  • World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed. Available at: http://www.who.int/reproductive-health/publications/mec. Accessed 8 June 2016.

Download references

Author information

Authors and Affiliations

  1. Division of Adolescent and Young Adult Medicine, Children’s National Health System, George Washington University, Washington, DC, USA

    Jean Someshwar M.D.

  2. Division of Adolescent Medicine and Eating Disorders, Penn State Hershey Children’s Hospital, Hershey, PA, USA

    Rollyn M. Ornstein M.D.

Authors
  1. Jean Someshwar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rollyn M. Ornstein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rollyn M. Ornstein M.D. .

Editor information

Editors and Affiliations

  1. Assistant Professor, Pediatrics, Program Director, Post-doctoral Fellowship in Adolescent Medicine, Division of Adolescent Medicine, Children’s Hospital at Montefiore, The Pediatric Hospital for Albert Einstein College of Medicine, Bronx, NY, USA

    Hina J. Talib M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Someshwar, J., Ornstein, R.M. (2018). Case of a Girl on Psychotropic Medications Seeking Birth Control. In: Talib, H.J. (eds) Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-66978-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66978-6_21

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66977-9

  • Online ISBN: 978-3-319-66978-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation